ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2026 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2026 Earnings Call Transcript September 15, 2025

ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.06496 EPS, expectations were $-0.04.

Operator: Good morning, ladies and gentlemen, and thank you for joining us today for MindWalk’s First Quarter Fiscal 2026 Earnings Call. We appreciate your time and interest in MindWalk, formerly ImmunoPrecise Antibodies. Today’s call will be led by our CEO, Dr. Jennifer Bath and...